Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04979416 · ClinicalTrials.gov registry record · NA

Video Messages and Vaccination Intention

A NA study of COVID-19 Vaccination, sponsored by University of Southern California.

Completed
Registry status
NA
Development phase
1,001
Enrollment target
1
Study location

NCT04979416: Completed NA study of COVID-19 Vaccination, sponsored by University of Southern California.

NCT04979416 is a NA study of COVID-19 Vaccination that has completed, run by University of Southern California. The registered enrollment target is 1,001 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (29% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04979416, a NA study of COVID-19 Vaccination, has completed, sponsored by University of Southern California.

COMPLETED
Registry status
NA
Development phase
1,001 participants
Enrollment target
1
Study location

Study Summary

This study uses an online panel survey to test the impact of video messages on stated likelihood of COVID-19 vaccination. Participants, who have self-identified as unvaccinated against COVID-19, are randomly assigned to either no video message or 1 of 3 video messages to encourage vaccine take-up. The key endpoint is a question about the likelihood of getting vaccinated in the next 30 days.

Primary Outcome

Probability of getting vaccinated in the next 30 days

Conditions Studied

Interventions

  • BEHAVIORAL Video messages

Study Locations (1)

California

  • USC - Los Angeles

Trial Details

FieldValue
Enrollment Target 1,001 participants
Start Date 2021-07-21
Est. Completion 2021-07-22
Phase NA
University of Southern California

617 total trials

What the finished NCT04979416 record still lists

NCT04979416 is an interventional study that assigns participants to a tested intervention. Its 1,001 participants enrollment target places it among the larger protocols in the corpus, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (29% lower).

The record links to 1 condition, with COVID-19 Vaccination appearing as the primary indexed condition, and to 1 intervention - of which Video messages is the first listed.

NCT04979416 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT04979416 about?

NCT04979416 is a clinical study titled "Video Messages and Vaccination Intention". This study uses an online panel survey to test the impact of video messages on stated likelihood of COVID-19 vaccination. Participants, who have self-identified as unvaccinated against COVID-19, are randomly assigned to either no video message or 1 of 3 video messages to encourage vaccine take-up. T...

What is the current status of trial NCT04979416?

This trial is currently completed. It is a NA study. The enrollment target is 1,001 participants. The study started on 2021-07-21. Estimated completion is 2021-07-22.

What conditions does trial NCT04979416 study?

This clinical trial studies the following conditions: COVID-19 Vaccination.

What interventions are being tested in trial NCT04979416?

The interventions under investigation include: Video messages (BEHAVIORAL).

Who is sponsoring clinical trial NCT04979416?

This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04979416 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for COVID-19 Vaccination

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04979416's enrollment target sits among peer trials

1,001 106th of 2000 higher than 1,894 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06207864 · 1,001 participants · NA

    Engagement of American Indians of Southwestern Tribal Nations in Cancer Genome Sequencing

  • NCT00018044 · 1,000 participants

    Study of Mycobacterial Infections

  • NCT01036581 · 1,000 participants · NA

    Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging

  • NCT01192048 · 1,000 participants

    Genetics of Congenital Heart Disease

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04979416, the US trial registry maintained by the National Library of Medicine. NCT04979416 (large enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.